The Venture Codex Logo

The Venture Codex

Overview

Next-generation gene editing technology for life sciences.

Total Raised

$176 M

Rounds

3

Links

Verticals

Biotechnology
Genetics
Health Care
Medical

Investment History

  1. Convertible Note

    Mar 2019

    $40M

  2. Series B

    Jun 2018

    $110M

  3. Series A

    May 2015

    $26M

Team

Matthew Kane

Co-Founder & Chief Executive Officer

Michael Amoroso

President & CEO

Derek Jantz

Co-Founder and Chief Scientific Officer

Jeff Smith

Co-Founder, Chief Technical Officer and Chief Science Officer